Ectopic or tertiary lymphoid tissues, such as inducible bronchus-associated lymphoid tissue (iBALT), form in nonlymphoid organs after local infection or inflammation. However, the initial events that promote this process remain unknown. Here we show that iBALT formed in mouse lungs as a consequence of pulmonary inflammation during the neonatal period. Although we found CD4 + CD3 − lymphoid tissue-inducer cells (LTi cells) in neonatal lungs, particularly after inflammation, iBALT was formed in mice that lacked LTi cells. Instead, we found that interleukin 17 (IL-17) produced by CD4 + T cells was essential for the formation of iBALT. IL-17 acted by promoting lymphotoxin-a-independent expression of the chemokine CXCL13, which was important for follicle formation. Our results suggest that IL-17-producing T cells are critical for the development of ectopic lymphoid tissues.
Inducible bronchus-associated lymphoid tissue (iBALT) is an ectopic lymphoid tissue that forms in the lungs after pulmonary inflammation or infection 1,2 . Like conventional lymphoid tissues, iBALT has separated B cell and T cell areas, follicular dendritic cells (FDCs), resident dendritic cells (DCs), high endothelial venules and lymphatics 3 . Once formed, iBALT collects antigen and antigen-bearing DCs from the airways and primes naive B cells and T cells 3, 4 , supports germinal center reactions 3 and generates effector and memory T cells as well as longlived plasma cells that seed the lung and bone marrow 5, 6 . Memory T cells and B cells as well as plasma cells are maintained in iBALT and respond locally to secondary challenge 5 . Thus, iBALT promotes rapid and efficient immune responses to pulmonary pathogens.
In humans, iBALT is often associated with chronic diseases, such as rheumatoid arthritis 7 , tuberculosis 8 and chronic obstructive pulmonary disease 9 . Each of these diseases is associated with persistent exposure to antigen or, in chronic obstructive pulmonary disease, exposure to cigarette smoke, which causes chronic inflammation and initiates the formation of ectopic lymphoid follicles, a process known as lymphoid neogenesis 2,10,11 . The developmental pathways that lead to lymphoid neogenesis have been studied extensively and closely parallel the pre-programmed development of conventional lymph nodes 2, 11 . For example, lymph node development is initiated by lymphoid tissue-inducer cells (LTi cells), which promote the differentiation of mesenchymal cells into stromal cell types that recruit and organize lymphocytes 12 . LTi cells express the chemokine receptors CXCR5 and CCR7, which promote the homing of LTi cells to sites of future lymph node development 13 . Once there, LTi cells express lymphotoxin-α 1 β 2 (ref. 14) , which engages its receptor (LTβR) on mesenchymal cells and initiates their differentiation and maintains expression of the chemokine CXCL13 (the ligand for CXCR5) and the chemokines CCL19 and CCL21 (the ligands for CCR7) 15 . These same molecules are involved in lymphoid neogenesis, as transgenic expression of CXCL13 (ref. 16 ), CCL21 (ref. 17) or lymphotoxin-α 10 in nonlymphoid organs promotes the development of fully functional ectopic lymphoid organs. Moreover, these chemokines and cytokines have high expression in ectopic lymphoid tissues that develop in response to infection or inflammation 3, 18 , and their blockade or genetic deletion disrupts follicle formation 19, 20 . Despite the parallels between conventional lymph node development and the formation of ectopic follicles, the initial events and the cell types that begin the process of lymphoid neogenesis remain unknown.
Here we show that mouse iBALT after lipopolysaccharide (LPS)-induced inflammation developed more easily in neonates than in adults and persisted for months in the absence of additional stimulation. Despite this developmental window, the formation of iBALT occurred independently of LTi cells, which required the transcription factors RORγ and Id2, and instead depended on the production of interleukin 17 (IL-17) by T cells. In turn, IL-17 triggered the lymphotoxin-independent expression of CXCL13 and CCL19, which recruited and organized lymphocytes. Once established, the architecture of iBALT was maintained by homeostatic expression of CXCL13, CCL19 and lymphotoxin. Thus, we have defined a previously unknown step in the formation of ectopic lymphoid follicles.
RESULTS

Development of iBALT after pulmonary inflammation in neonates
In mice that lack conventional secondary lymphoid organs, iBALT forms easily after influenza infection 3, 5, 18 . However, a single infection A r t i c l e s of adult C57BL/6 mice with influenza elicited only disorganized lymphoid clusters consisting mainly of B cells (data not shown). Given the link between chronic inflammation and the formation of ectopic follicles, we attempted to establish iBALT by repeatedly administering LPS to the lungs of C57BL/6 mice and then infecting the mice with influenza, but again we observed disorganized lymphoid clusters rather than discrete areas of iBALT (data not shown). On the basis of published studies showing that the injection of developing lymph node stroma into the skin of neonatal mice leads to the formation of ectopic lymphoid tissues 21 , we next administered LPS intranasally to neonatal mice, infected them with influenza when they were 6 weeks old and then examined the lungs by histology 3 weeks later. We found that mice treated in this way developed highly organized areas of iBALT containing multiple B cell follicles separated by well-defined T cell areas (Fig. 1a) . In contrast, when we did a similar procedure, but administered LPS to 2-week-old mice (Fig. 1b) or to 3-week-old mice (Fig. 1c) , the mice developed disorganized B cell clusters that lacked defined T cell areas or FDC networks. We obtained similar results over a range of LPS doses (1-10 µg) and when we substituted CpG oligonucleotides for LPS (data not shown).
To determine whether the combination of LPS and influenza was unique in its ability to trigger iBALT formation, we administered either PBS (Fig. 1d) or LPS (Fig. 1e) to neonatal mice, then administered LPS to both groups when they were 6 weeks old and did histology 3 weeks later. Again we found that mice treated with LPS as adults did not form organized iBALT areas (Fig. 1d) , whereas mice treated with LPS as neonates and then again as adults formed well-defined areas of iBALT (Fig. 1e) . Thus, pulmonary exposure to inflammatory stimuli during a narrow developmental window in neonatal mice promoted the formation of iBALT.
Role of monocytes and DCs in iBALT formation
Published data have shown that the maintenance of iBALT is dependent on CD11c + DCs 4, 6 . Given that LPS is a potent inflammatory stimulus, we hypothesized that it would promote the accumulation of DCs and other inflammatory cells in the lung that would facilitate the formation of iBALT. Consistent with our hypothesis, we found that intranasal administration of LPS to neonates resulted in substantial accumulation of neutrophils, monocytes and CD11b hi CD103 − DCs in the lung (Fig. 2a) but did not change the number of CD11b lo CD103 + DCs (Fig. 2a) . To confirm published data showing that CD11c + cells were required for the maintenance of iBALT, we studied mice that express a transgene encoding the diphtheria toxin receptor under control of promoter of the gene encoding CD11c and are transiently depleted of DCs after administration of diphtheria toxin. We administered LPS intranasally to neonatal mice with transgenic expression of the diptheria toxin receptor, administered diphtheria toxin 1 d before the final administration of LPS and collected lungs 1 week later. As expected, we found very few and much smaller iBALT areas in diphtheria toxin-treated mice (data not shown). Thus, CD11c + cells were important for the formation of iBALT in LPS-treated neonatal mice, just as they were in influenza-infected adult mice.
As monocytes are typically recruited to inflammatory sites via the chemokine receptor CCR2 (ref. 22) , and some populations of DCs in mucosal lymphoid tissues are dependent on the chemokine receptor CCR6 (ref. 23 ), we next assessed whether CCR2 or CCR6 was important for the formation of iBALT. However, we found that iBALT developed normally in both Ccr2 −/− mice and Ccr6 −/− mice (Fig. 2b) . In addition, the total area of the lymphoid follicles in Ccr2 −/− mice and Ccr6 −/− mice was indistinguishable from that in wild-type C57BL/6 mice (Fig. 2c) . Finally, we observed that CXCL13 and CCL19, chemokines important for the organization of lymphoid tissues 15 , were induced to the same extent in C57BL/6, Ccr2 −/− and Ccr6 −/− mice (Fig. 2d) . Thus, despite the dependence of iBALT on DCs, neither CCR2 nor CCR6 was required for the normal development of iBALT.
Formation of iBALT independently of LTi cells
The development of conventional secondary lymphoid organs is dependent on the activity of CD4 + CD3 − LTi cells 24, 25 . Given that LTi cells are more prevalent in neonatal mice than in adult mice, we hypothesized that neonatal exposure to LPS would result in the recruitment of LTi cells to the lung, where they would trigger the development of iBALT. To test our hypothesis, we initially counted CD4 + lineage-negative (Lin − ) cells in the lungs of PBS-treated and LPS-treated neonatal mice. We found that CD4 + Lin − cells were present in the lungs of both groups but that the frequency of these cells was about fourfold higher in the LPS-treated group (Fig. 3a) . In addition, there were threefold more CD4 + Lin − cells and fourfold more CD4 + CXCR5 + Lin − cells in LPS-treated lungs (Fig. 3b) .
To determine whether LTi cells were required for the formation of iBALT, we administered LPS to neonatal RORγ-deficient (Rorc −/− ) A r t i c l e s mice and Id2-deficient (Id2 −/− ) mice, both of which fail to develop LTi cells and, consequently, lack lymph nodes 26, 27 . We also administered LPS to neonatal lymphotoxin-α-deficient (Lta −/− ) mice and to neonatal mice lacking the chemokines CXCL13, CCL19 and CCL21a, both of which fail to develop lymph nodes because of poor differentiation of mesenchymal cells and poor homing of LTi cells 28, 29 . We found that both Rorc −/− mice and Id2 −/− mice developed normal iBALT areas ( Fig. 3c) , but although B cells and T cells accumulated in Lta −/− mice, they were not separated into distinct areas, FDCs did not form, and high endothelial venules expressing peripheral node addressin were undetectable (Fig. 3c) . We obtained similar results when we used soluble LTβR to block the engagement of LTβR (data not shown). Finally, the mice deficient in CXCL13, CCL19 and CCL21a accumulated B cells and T cells in their lungs, but they failed to form distinct zones and FDCs were not apparent. However, these mice deficient did form high endothelial venules expressing peripheral node addressin ( Fig. 3c) . Thus, it seems that the formation and organization of iBALT does not require RORγ-dependent or Id2-dependent LTi cells but does require lymphotoxin-α and homeostatic chemokines for lymphoid organization.
IL-17 contributes to iBALT formation
As LTi cells were not required for the formation of iBALT, it was not immediately apparent why iBALT tended to develop in neonatal mice rather than adult mice. Therefore, we next examined the expression of a variety of candidate genes that might have differences in expression in neonatal and adult mice after pulmonary exposure to LPS. We found that lymphotoxin-β and LIGHT, both ligands for LTβR, were induced after LPS exposure but were induced in weanlings and adult mice in an abundance similar to or greater than that in neonatal mice (Fig. 4) . The expression of CCL19 was also induced similarly in neonates, weanlings and adults. However, LPS induced higher CXCL13 expression in neonates than in either weanlings or adults, and expression of the p19 subunit of IL-23 (IL-23p19) and IL-17A was induced much more in neonates and weanlings than in adults (Fig. 4) . As IL-23 is important for the stability of IL-17-producing T cells 30 , these results suggested that IL-17-producing 
A r t i c l e s
T cells may accumulate more readily in the lungs of neonatal mice and may promote the formation of iBALT.
To determine whether IL-17 has a role in the development of iBALT, we administered LPS to mice with various deficiencies (Fig. 5a-e) . We found that although iBALT areas were present in the lungs of mice deficient in IL-17 receptor A (IL-17RA; Fig. 5b ), these structures were smaller and less numerous than those in C57BL/6 mice. In contrast, we found iBALT areas of normal size and composition, but fewer in number, in LPS-treated mice deficient in IL-23p19 (Fig. 5c) . We also found that iBALT formation was impaired in IL-17A-deficient mice (Fig. 5d) . Finally, even though the number and size of iBALT areas were diminished in IL-17RA-deficient mice and IL-17A-deficient mice, the architecture of the remaining iBALT areas was not as disrupted as it was in Lta −/− mice (Fig. 5e) .
To obtain a more quantitative assessment of iBALT in the various strains of mice, we did morphometric analysis and determined the number and size of lymphoid areas, B cell follicles and FDC networks observed by histology and calculated the total area of iBALT in a typical section (Fig. 5f ). Together these data support the conclusion that IL-17A and, to a lesser extent, IL-23 are important for the formation of iBALT.
Given the fact that IL-17 signaling promotes the expression of CXCL9, CXCL10 and CXCL11, which in turn recruit inflammatory cells, we hypothesized that IL-17 may also trigger the expression of CXCL13, CCL19, and CCL21, all of which are involved in the initial formation of conventional lymphoid organs and help to maintain their structure 28 . We found that the expression of both CXCL13 and CCL19, but not the expression of CCL21, was induced in the lungs of LPStreated C57BL/6 mice, but the expression of these chemokines was not induced to the same extent in IL-17RA-deficient mice (Fig. 5g) . In contrast, LPS induced normal expression of both CXCL13 and CCL19 in IL-23p19-deficient mice and Lta −/− mice (Fig. 5g) . As a control, we also examined the expression of CXCL9, CXCL10 and CXCL11, chemokines known to be induced in response to IL-17. As expected, we found that LPS resulted in substantially higher expression of these chemokines and that the loss of IL-17RA resulted in lower expression (Fig. 5h) . In contrast, the expression of CXCL9, CXCL10 and CXCL11 was not impaired in mice deficient in IL-23p19 (Fig. 5h) . Finally, the expression of CXCL10 and CXCL11 was slightly lower in Lta −/− mice, although not to the extent it was in IL-17RA-deficient mice (Fig. 5h) .
To confirm by an independent method that IL-17 promoted the expression of CXCL13 and CCL19, we isolated pulmonary fibroblasts from neonatal mice, cultured them for 6 h with recombinant IL-17A or tumor necrosis factor (TNF) and analyzed the expression of homeostatic chemokines by quantitative PCR. Consistent with the results obtained with whole lungs, we found that treatment with IL-17A or TNF promoted higher expression of both CXCL13 and CCL19 but not of CCL21 (Fig. 5i) . However, combined treatment with both IL-17A and TNF did not result in higher expression of either CXCL13 or CCL19 above that obtained with either cytokine alone (data not shown).
IL-17A is needed to initiate but not to maintain iBALT
To determine the kinetics and duration of iBALT formation, we administered LPS intranasally to neonatal mice and did histology at various times after the final administration of LPS. We observed rudimentary iBALT structures within 6 h of the final LPS dose; these consisted of small clusters of B cells and T cells with nascent FDC networks (Fig. 6a) . However, within 1 week of the final LPS dose, we observed well-developed B cell follicles that were maintained for at least 10 weeks in the absence of additional stimulation (Fig. 6a) . After pulmonary infection with influenza, the iBALT areas enlarged (Fig. 6a) and in many cases developed germinal centers (data not shown), consistent with published observations 3 . We also quantified the size of FDC networks in iBALT at the various times after LPS administration and found that these rapidly expanded after cessation of LPS administration and then gradually decreased over time in the absence of new stimulation. However, FDC networks expanded again after influenza infection (Fig. 6b) . Thus, iBALT formed rapidly after acute inflammation and, once formed, persisted in the lung for at least several months.
To determine at what steps IL-17 and lymphotoxin were important in the formation of iBALT, we administered LPS intranasally to neonatal mice and treated them with either soluble LTβR or antibody to IL-17A (anti-IL-17A) before the final LPS treatment (before iBALT formation) or 1 week after the final LPS treatment (when iBALT had already formed) and counted iBALT areas in the lungs 1 week later. We found that treatment with soluble LTβR or anti-IL-17 resulted in fewer B cell clusters and FDC networks when given before iBALT formation but not when given after iBALT formation (Fig. 6c, top) . In contrast, the B cell clusters and FDC networks were smaller after LTβR blockade both before and after iBALT formation, whereas B cell clusters were smaller after treatment with anti-IL-17 only when it was given before iBALT formation (Fig. 6c, middle) . Overall, we found that LTβR blockade resulted in smaller total areas of B cell clusters and FDC networks when give either before or after iBALT formation, whereas IL-17A blockade affected the total areas of B cell clusters and FDC networks only when given before iBALT formation (Fig. 6c, bottom) . Thus, we conclude that IL-17 signaling is involved during the initiation of iBALT formation but is not involved in the maintenance of iBALT, whereas lymphotoxin signaling seems to be involved in both early and late steps.
Contribution of IL-17-producing T cells to iBALT formation
To determine which cells produce IL-17 in the lungs of LPS-treated mice, we purified naive CD4 + T cells from adult spleens and non-T cells, αβ T cells, γδ T cells and total CD4 + cells from the lungs of LPStreated neonatal mice and assayed IL-17A expression by quantitative PCR. We found that naive CD4 + cells as well as non-T cells from the lungs of LPS-treated mice expressed little IL-17 (Fig. 7a) , whereas αβ T cells, γδ T cells and CD4 + cells from the lungs of LPS-treated mice had abundant expression of IL-17 (Fig. 7a) . To determine whether IL-17-expressing cells had any physical proximity to iBALT, we probed sections of LPS-treated neonatal lungs with anti-IL-17A. We found that essentially all IL-17A-producing cells in developing iBALT areas also expressed CD4 (Fig. 7b) . Given that both αβ T cells and γδ T cells expressed IL-17 and that many of the γδ T cells in the lung also expressed CD4 (data not shown), we also assessed the presence of these two cell types in iBALT areas. We found CD3 + T cells surrounding the B cell follicle in iBALT (Fig. 7c) and found CD3 + γδ T cells in a similar area (Fig. 7d) . Moreover, the CD3 + γδ T cells accounted for about one third of the T cells present in iBALT, which suggested A r t i c l e s that αβ T cells (both CD4 + and CD8 + ) accounted for the remainder. Thus, both αβ T cells and γδ T cells are present in iBALT and probably contribute to the production of IL-17.
To directly determine the contribution of T cells to the formation of iBALT, we next administered LPS to neonatal T cell-deficient (Tcrb −/− Tcrd −/− ) mice. We found that LPS-treated Tcrb −/− Tcrd −/− mice formed fewer and smaller B cell clusters than those of C57BL/6 mice and that these clusters completely lacked FDC networks (Fig. 7a) . However, when we adoptively transferred CD4 + T cells from the lymph nodes of LPS-treated mice to neonatal mice before administering LPS, we again observed normal formation of iBALT (Fig. 7e) . As Tcrb −/− Tcrd −/− mice could still have had LTi cells that might have contributed to the formation of iBALT, we next administered LPS to neonatal Rorc −/− mice that had been depleted of CD4 + T cells or left undepleted. We found well-developed iBALT areas in undepleted Rorc −/− mice but only a few small clusters of B cells in Rorc −/− mice depleted of CD4 + T cells (Fig. 7f) . As a control, we found that this depletion eliminated both CD4 + αβ T cells and CD4 + γδ T cells (Fig. 7g) . Thus, iBALT development is dependent on CD4 + T cells.
To determine whether αβ T cells or γδ T cells tended to contribute to iBALT formation, we purified γδ T cells and αβ T cells from LPStreated neonatal mice and adoptively transferred those populations into LPS-treated neonatal Tcrb −/− Tcrd −/− mice. We found that γδ T cells facilitated the development of iBALT but that αβ T cells generated larger areas of iBALT and that the transfer of both subsets provided an additive effect (Fig. 7h) . Given that conventional αβ T cells efficiently generated iBALT, we next determined whether IL-17-producing helper T cells (T H 17 cells) induced iBALT. To assess this possibility, we activated ovalbumin (OVA)-specific OT-II T cells in vitro under conditions that would generate CXCR5-expressing follicular helper T cells (T FH cells) or IL-17-producing T H 17 cells or a combination of conditions that would generate CXCR5-expressing, IL-17-producing T FH cells (Fig. 7i) . We then transferred those cells into neonatal Tcrb −/− Tcrd −/− mice, which we then treated with LPS and OVA. Although we found occasional areas of iBALT in mice that received T FH cells (Fig. 7i) , we found larger and more numerous areas of iBALT in mice that received T H 17 cells and many more (and larger) areas in mice that received IL-17-producing T FH cells (Fig. 7j) . As controls, we also transferred T helper type 1 cells or T helper type 2 cells, which were the weakest inducers of iBALT formation (data not shown). Thus, CXCR5-expressing, IL-17-producing T FH cells efficiently triggered the formation of ectopic follicles in the lung.
DISCUSSION
Here we have shown that IL-17-producing T cells were involved in the formation of ectopic lymphoid follicles in the lung and that IL-17 seemed to act by triggering the expression of CXCL13 and CCL19 independently of lymphotoxin signaling. Thus, we propose a new model of ectopic follicle formation in which the initial step is the production of IL-17 by non-LTi cells, such as T cells. In turn, IL-17 promotes the expression of CXCL13 and CCL19, which recruit B cells and T cells and maintain the structure of FDC networks. Once the initial inflammatory response resolves, the expression of CXCL13 and CCL19 as well as the overall architecture of iBALT is maintained by the homeostatic interaction of lymphotoxin-expressing lymphocytes with LTβR-expressing stromal cells or vascular endothelial cells. Our model is also consistent with the requirement for T cells, but not for LTi cells, in the formation of ectopic follicles in mice transgenically expressing CCL21 in the thyroid 31 . Moreover, our data suggest that simultaneously targeting both IL-17 and lymphotoxin signaling pathways may be beneficial in diseases such as Sjogren's syndrome or multiple sclerosis, in which the development of ectopic follicles is linked to local pathology. An additional observation from our studies is that iBALT formed much more easily in neonatal mice than in adult mice, a finding that we initially attributed to the greater frequency of LTi cells in neonates. However, our results obtained with Rorc −/− and Id2 −/− mice suggested that LTi cells were not required for the development of iBALT, a scenario similar to the RORγ-and Id2-independent development of tear duct-associated lymphoid tissue 32 and the milky spots of the omentum 33 , as well as the RORγ-independent (but Id2-dependent) development of nasal-associated lymphoid tissue 34, 35 . All these tissues develop in the neonatal period and may be dependent on different types of LTi cells or perhaps IL-17-producing T cells. A caveat to this explanation is that in addition to being important for the development of LTi cells, RORγ was important for the production of IL-17 by T cells-both αβ T cells 36 and γδ T cells (data not shown). Thus, the formation of ectopic lymphoid tissues in Rorc −/− mice may rely on compensatory mechanisms, as suggested by studies assessing the development of ectopic follicles in the colons of Rorc −/− mice 37 . Alternatively, despite less IL-17 production by Rorc −/− T cells, the residual IL-17 produced by T cells may trigger low expression of CXCL13 in the lung, which may be sufficient to recruit lymphocytes and initiate lymphoid organogenesis in mice lacking conventional secondary lymphoid organs.
If it is assumed that iBALT formation is not dependent on LTi cells but is instead dependent on IL-17-producing T cells, a different hypothesis is needed to explain the tendency for iBALT to develop in neonatal mice rather than adult mice. For example, γδ T cells first emerge from fetal progenitors before αβ T cells do 38 , which suggests that they are the first T cells available during the neonatal period. The γδ T cells also express IL-17 in response to microbial products 39 , and many γδ T cells are located in the lung, where they would be positioned to promote iBALT development. Moreover, regulatory T cells are not exported to the periphery during the first week after birth and as a result, neonatal thymectomy leads to autoimmunity 40 . Given that the lack of proper homing of regulatory T cells in CCR7-deficient mice seems to promote spontaneous iBALT formation 41 , it is possible that the relative paucity of regulatory T cells and relative abundance of IL-17-producing γδ T cells in neonates may ease the formation of iBALT after pulmonary inflammation. The tendency for iBALT to form in neonatal mice rather than adult mice is also consistent with the observations that in humans, iBALT is infrequently found in healthy adults 42, 43 but is more frequently found in the lungs of healthy children 44 . Moreover, the incidence of iBALT approaches 100% in the lungs of neonatal humans with pulmonary infection 45 .
Of course, the formation of iBALT is not restricted exclusively to the neonatal period, as iBALT is observed in adult mice after pulmonary viral infection 4, 6 or bacterial infection 46, 47 , as well as after the pulmonary administration of cigarette smoke 48 , particulates or protein nanoparticles 49 . It is also observed in patients with a variety of inflammatory conditions, such as chronic obstructive pulmonary disease 9 and rheumatoid arthritis 7 . Although these conditions often develop in adults, it is unknown whether the patients with iBALT experienced pulmonary inflammation as neonates, which may have conditioned their lungs to form iBALT as adults. Nevertheless, we suggest that conditions that lead to the recruitment and activation of any IL-17-producing cell type, including γδ T cells, T H 17 cells, natural killer cells and LTi cells, probably lead to the development of ectopic structures, particularly if the stimulus is chronic, as in rheumatoid arthritis 50 and multiple sclerosis 51 or after chronic infection. Given the association of T H 17 cells with bacterial infection 52 , it is not unexpected that the frequency of T H 17 cells in a particular person is dependent on their history of exposure to pathogens and even commensal bacteria in the gut. Similar observations have been made about mice. In particular, mice exposed to segmented filamentous bacteria in the gut have a high frequency of T H 17 cells 53 . As mice from different commercial vendors and institutional colonies have very different gut flora, including segmented filamentous bacteria, each colony has a different frequency of T H 17 cells, which leads to different biological outcomes in terms of inflammatory diseases, including autoimmunity 54 . The mice used in our study were imported to the Trudeau Institute, where they were rederived by transfer of embryos into germ-free foster mothers that were reconstituted with altered Schaedler flora, a mixture of eight species that does not include segmented filamentous bacteria 55 . These mice were then maintained in a barrier facility at Trudeau Institute and then were imported to a barrier facility at the University of Rochester. Therefore, we suspect that the limited diversity of gut flora in our mice is one reason that we did not observe the development of iBALT in adult mice exposed to influenza infection or given LPS intranasally. In contrast, other investigators using genetically identical mice will probably obtain different results depending on the gut flora in their colonies.
In summary, our results have established a new paradigm for how ectopic lymphoid follicles form in nonlymphoid tissues and have shown that the initial step in ectopic follicle formation was dependent on IL-17. That triggered maturation of the FDC network and promoted the expression of CXCL13 and CCL19 independently of lymphotoxin. In turn, those chemokines recruited lymphocytes, which formed organized B cell and T cell domains that were maintained by lymphotoxin-dependent homeostatic mechanisms once inflammation was resolved.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
